MedTrace Logo

COVID-19, Aging, and Cardiometabolic Risk Factors Study

NCT04802044 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2022-04-18

No results posted yet for this study

Summary

COVID-19 pandemic has made a tremendous impact on Indonesian economic and health care system especially with the double burden of diseases facing by Indonesia as a developing country. The prevalence of non-communicable diseases such as obesity, type diabetes, and cardiovascular diseases is increasing. These diseases along with older age have been known as an established risk factors for higher mortality and severe clinical disease entity in COVID-19 infection. Although, there is still some part of patients with these co-morbidities that only present with mild symptoms when infected with SARS-CoV-2, even for some without any symptoms. Thus, it would be very interesting to evaluate how are these role of aging and cardiometabolic parameters in the clinical disease course of COVID-19 infection, and how are the relationship with the immune system.

Conditions

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Indonesia University

    lead OTHER

Principal Investigators

  • Dicky L Tahapary · Indonesia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-08
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04802044 on ClinicalTrials.gov